Secondary and post hoc analyses of REDEFINE 1 (3,417 adults with overweight or obesity): CagriSema lowered systolic BP by 10.9 vs 2.8 mm Hg with placebo at week 68; 63.0% vs 32.0% reached BP targets.
Secondary analysisn = 3,417
Verma et al. CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1